Medical Perfusion Technology Market is expected to reach US$ 962.60 Mn by 2027 With Getinge AB, Medtronic, LivaNova PLC, Terumo Corporation, XVIVO Perfusion, OrganOx Limited, Waters Medical Systems LLC, TransMedics, Organ Recovery Systems, and Xenios AG

According to our new research study on “Medical Perfusion Technology Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Technique, Organ Type, and Component,” the market is expected to reach US$ 962.60 million by 2027 from US$ 707.10 million in 2019. The market is estimated to grow at a CAGR of 4.1% from 2020 to 2027. Factors such as rise in prevalence of cardiovascular diseases, significant growth of pharmaceutical and biotechnology industries, increase in need for organ transplantation, and rise in cell-based research activities play a vital role in the growth of the medical perfusion technology market. However, the challenges such as expensive organ transplant surgeries and limited numbers of donors for organ transplant surgeries are likely to impact the growth of the market during the forecast period. On the other hand, technological developments in the emerging nations are likely to provide a significant opportunity for the market growth in the coming years.

Request Sample Copy of Medical Perfusion Technology Market at: https://www.theinsightpartners.com/sample/TIPRE00019844/?openpr-10225

Based on technique, the medical perfusion technology market is segmented into hypothermic machine perfusion and normothermic machine perfusion. The hypothermic machine perfusion segment held larger share of the market in 2019. However, the normothermic machine perfusion segment is estimated to register higher CAGR of 4.4% in the market during the forecast period.

Getinge AB, Medtronic, LivaNova PLC, Terumo Corporation, XVIVO Perfusion, OrganOx Limited, Waters Medical Systems LLC, TransMedics, Organ Recovery Systems, and Xenios AG – a Fresenius Medical Care are among the leading companies operating in the medical perfusion technology market. The companies are adopting inorganic and organic growth strategies to expand their global footprints and product portfolio to meet the rising demands for the medical perfusion technology. For instance, in May 2019, Terumo Cardiovascular Group, a world pioneer in cardiovascular surgery technology, and Talis Clinical, a major supplier of healthcare software solutions, have announced the commercial availability of ACG-Perfusion and ACG-RemoteView Systems in North America.

The report segments global medical perfusion technology market as follows:

By Software Type

Hypothermic Machine Perfusion
Normothermic Machine Perfusion

By Organ Type

Heart
Lung
Kidney
Liver
Others

By Component

Perfusion Pumps
Oxygenators
Heart-Lung Machines
Monitoring Systems
Cannulas
Others

By Geography

North America
US
Canada
Mexico
Europe
France
Germany
UK
Spain
Italy
Rest of Europe
Asia Pacific (APAC)
China
India
Japan
Australia
South Korea
Rest of APAC
Middle East & Africa (MEA)
Saudi Arabia
UAE
South Africa
Rest of MEA
South and Central America (SCAM)
Brazil
Argentina
Rest of SCAM

!!! Due TO Covid-19 (coronavirus) pandemic Limited Time DISCOUNT Available!!! Get Your Copy at Discounted Price !!!

Interested in purchasing Medical Perfusion Technology Research Report? Click here @ https://www.theinsightpartners.com/buy/TIPRE00019844/?openpr-10225

Contact Us:
The Insight Partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.
We understand syndicated reports may not meet precise research requirements of all our clients. We offer our clients multiple ways to customize research as per their specific needs and budget

This release was published on openPR.